Litcius/Paper detail

Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series

the COVID-BioB Study Group, Alberto Zangrillo, Giovanni Landoni, Luigi Beretta, Federica Morselli, Ary Serpa Neto, Rinaldo Bellomo

2020Critical Care49 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Vasodilation2019-20 coronavirus outbreakShock (circulatory)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Series (stratigraphy)Angiotensin IIVasoconstrictor AgentsCardiologyIntensive care medicineInternal medicineVirologyBlood pressureDiseaseOutbreakPaleontologyInfectious disease (medical specialty)BiologyCOVID-19 Clinical Research StudiesMuscle and Compartmental DisordersLong-Term Effects of COVID-19
Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series | Litcius